医学
便秘
功能性便秘
乳果糖
随机对照试验
儿科
婴儿配方奶粉
小儿胃肠病
合生元
梅德林
临床试验
重症监护医学
内科学
益生菌
疾病
政治学
细菌
法学
生物
遗传学
作者
Laurine Steurbaut,Elvira Ingrid Levy,Charlotte De Geyter,Stefanie Buyse,Yvan Vandenplas
标识
DOI:10.1080/17474124.2023.2242255
摘要
Introduction Functional constipation is one of the common disorders of gut–brain interaction in infancy, and decreases the quality of life of infants and parents.Areas covered Relevant articles up to November 2022 were reviewed. We searched in PubMed, Google Scholar, and MEDLINE for guidelines, position papers, reviews, and randomized controlled trials on infant constipation.Expert opinion Randomized controlled trials in this specific age group are mostly limited to trials with infant formula. The prevalence of infant constipation in formula-fed infants is decreasing, and can be associated with adaptations in formula composition. While the supplementation of infant formula with pro-, pre- and/or synbiotics decreases the prevalence of constipation, their efficacy in constipated infants is disappointing. There is limited evidence to support the addition of magnesium to infant formula to treat constipation. The evidence for the efficacy and safety of polyethylene glycol in children < 2 years has expanded over the past years. The administration of lactulose or polyethylene glycol is the preferred medical management, in case nutritional management does result in insufficient improvement.
科研通智能强力驱动
Strongly Powered by AbleSci AI